COVID-19 Virtual Care at Home

Covid-19 Clinical Trial

Official title:

COVID-19 Virtual Care at Home

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04420182
• Other study ID #: CTO 3210
• Status: Completed
• Phase: N/A
• Start date: August 17, 2020
• Est. completion date: February 4, 2022

Study information

• Verified date: April 2022
• Source: Lawson Health Research Institute
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This multicentre prospective cohort trial is designed to demonstrate effectiveness and efficiency of a virtual care model for the management of COVID-19 patients isolating at home. The investigators have reoriented existing technology and networks for this research project. The investigators are amplifying our existing virtual care platform VIRTUES, combining it with home monitoring of COVID-19 patients, to provide real-time evidence, harmonize data collection, and share data provincially to mitigate the impact of the rapid spread of the virus. The study will facilitate early detection of complications associated with the disease, treatment and management of COVID-19 patients at home. The research will be conducted provincially in Ontario.

This initiative will provide evidence to inform clinical and health system management and public health response to COVID-19 patients isolating at home.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 817
• Est. completion date: February 4, 2022
• Est. primary completion date: February 4, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• All COVID-19 positive patients of age 18 or above

• Participant must communicate in English or French language

• An email address and account

Exclusion Criteria:

• Unable or unwilling to provide informed consent

Related Conditions & MeSH terms

• Covid-19

Intervention

Other:
• Virtual Care at Home
Participants will have access to the VIRTUES platform for COVID-19 Virtual Care at Home

Locations

Country	Name	City	State
Canada	St. Mary's General Hospital	Kitchener	Ontario
Canada	London Health Sciences Centre	London	Ontario
Canada	Ottawa Heart Research Institute	Ottawa	Ontario
Canada	Niagara Health	St. Catharines	Ontario
Canada	St. Joseph's Health Centre	Toronto	Ontario

Sponsors (2)

Lead Sponsor	Collaborator
Lawson Health Research Institute	Cardiac Arrhythmia Network of Canada

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	14 Day Patient Satisfaction Questionnaire	The primary outcome measure is patient satisfaction as measured from a patient satisfaction questionnaire at 14 days.	14 days
Secondary	Emergency Department Visits	The secondary outcome measures will include the number of patients that require an Emergency Department visits during the observation period of 14 days.	14 days
Secondary	14 Day EQ-5D-5L Scores	The secondary outcome measures will include the health status measures of the EuroQuality of Life Five Dimensions (EQ-5D-5L) at 14 days. Scoring is Level 1 to 5 for each dimension; higher scores meaning worse health status.	14 days